Although western blot analysis showed that ATO treatment increased the amount of phosphorylated JNK, inhibition of JNK activity had no effect on osteosarcoma cell proliferation with or without ATO, as seen with Ewing sarcoma cells (Figure S1) [23]. The gene discussed is MAPK8; the disease is osteosarcoma.